A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster
Clinical trial NCT05609045 · WITHDRAWN
Trial details
- NCT number
- NCT05609045
- Sponsor
- Wuhan Rhegen Biotechnology Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2023-08-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.